Skip to main content
Quest Diagnostics

Association of ApoB-LDL-C Discordance with Cardio-Kidney-Metabolic Dysfunction in a Large National Laboratory Cohort

ASPC 2026

American Society for Preventive Cardiology

Scottsdale, AZ  July 31-Aug 2, 2026, 

Oral presentation: Association of ApoB-LDL-C Discordance with Cardio-Kidney-Metabolic Dysfunction in a Large National Laboratory Cohort

Authors: Tina K. Reddy, Anjali Bhatla, Carmen Tong, Robert Weinstein, Bhavya Ancha, Sanjay B. Dixit, Marc Penn, Seth S. Martin

Medical Specialty: Cardiolocy, Cardiovascular, Endocrinology

Related content

Audio Podcast
Instant Insights: Streamlining Cardiometabolic Disease Assessment
Audio Podcast
Instant Insight: Kidney Profile and Cystatin C
Audio Podcast
Instant Insights: Apolipoprotein B
On-Demand Webinar
Utilizing Apolipoprotein B in Cardiovascular Risk Assessment
On-Demand Webinar
Utilizing Lipoprotein(a) in Cardiovascular Risk Assessment
Audio Podcast
Instant Insight: Metabolic Risk Panel
Audio Podcast
Instant Insights: Lipoprotein Fractionation for Personalized Risk Assessment
On-Demand Webinar
The Continuum of Kidney Disease Care: From Identification to referral

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.